SAS
WST icon

Stelac Advisory Services’s West Pharmaceutical WST Stock Holding History

Stelac Advisory Services’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,809
Closed -$445K – 169
2022
Q3 		$445K Hold
1,809
– – 0.2% 85
2022
Q2 		$547K Buy
1,809
+1,041
+136% +$339K 0.22% 70
2022
Q1 		$315K Sell
768
-1,635
-68% -$640K 0.11% 70
2021
Q4 		$1.13M Sell
2,403
-62
-3% -$26.7K 0.31% 51
2021
Q3 		$1.05M Sell
2,465
-370
-13% -$156K 0.28% 53
2021
Q2 		$1.02M Buy
+2,835
New +$937K 0.23% 75

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stelac Advisory Services's WST Position: Q4 2022 in Review

Stelac Advisory Services sold out of West Pharmaceutical (WST) in Q4 2022, closing a stake of 1,809 shares — an estimated $445K sold.

Stelac Advisory Services first reported a position in WST in Q2 2021 and held it in 6 quarters. The position peaked at $1.13M in Q4 2021. 637 funds tracked by Wall St. Rank hold WST as of Q4 2022.

  • Stelac Advisory Services reported no remaining West Pharmaceutical position as of Q4 2022 after selling out during the quarter.
  • Stelac Advisory Services sold 1,809 West Pharmaceutical shares in Q4 2022, an estimated $445K.
  • Stelac Advisory Services first reported a position in West Pharmaceutical in Q2 2021 and held it in 6 quarters.
  • Stelac Advisory Services's West Pharmaceutical position peaked at $1.13M in Q4 2021.
  • 637 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2022.

Based on Stelac Advisory Services's 13F filing for Q4 2022, filed 14 Feb 2023.